Entera Bio Ltd. SEC filings ENTX
Entera Bio Ltd. has 418 filings in SEC EDGAR's recent list, going back to May 1, 2015. Its latest annual report, Form ARS, was filed on Jun 3, 2026 for the period ended Jun 3, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Oct 14, 2026 | Oct 14, 2026 |
| PRE 14A | Preliminary proxy statement | Sep 23, 2026 | Sep 23, 2026 |
| DEFA14A | Additional proxy material | Jun 3, 2026 | — |
| DEF 14A | Proxy statement | Jun 3, 2026 | Jun 3, 2026 |
| PRE 14A | Preliminary proxy statement | May 14, 2026 | May 14, 2026 |
| DEFA14A | Additional proxy material | Jun 5, 2025 | — |
| DEF 14A | Proxy statement | Jun 5, 2025 | Jun 5, 2025 |
| PRE 14A | Preliminary proxy statement | May 14, 2025 | May 14, 2025 |
| DEFA14A | Additional proxy material | Jun 20, 2024 | — |
| DEF 14A | Proxy statement | Jun 20, 2024 | Jun 20, 2024 |
| PRE 14A | Preliminary proxy statement | May 29, 2024 | May 29, 2024 |
| DEF 14A | Proxy statement | Aug 15, 2023 | Aug 15, 2023 |
| PRE 14A | Preliminary proxy statement | Jun 23, 2023 | Jun 23, 2023 |
| DEF 14A | Proxy statement | Jul 29, 2022 | Jul 29, 2022 |
| PRE 14A | Preliminary proxy statement | Jul 19, 2022 | Jul 19, 2022 |
Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ENTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Jerusalem
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1638097
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.